These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 24863745

  • 1. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
    Wang G, Wang F, Cao D, Liu Y, Zhang R, Ye H, Li X, He L, Yang Z, Ma L, Peng A, Xiang M, Wei Y, Chen L.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3158-63. PubMed ID: 24863745
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth.
    Xu F, Jia Y, Wen Q, Wang X, Zhang L, Zhang Y, Yang K, Xu W.
    Eur J Med Chem; 2013 Jun 15; 64():377-88. PubMed ID: 23644219
    [Abstract] [Full Text] [Related]

  • 3. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X, Wang X, Ye H, Peng A, Chen L.
    Cancer Chemother Pharmacol; 2012 Sep 15; 70(3):425-37. PubMed ID: 22814678
    [Abstract] [Full Text] [Related]

  • 4. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
    Ma L, Chen J, Wang X, Liang X, Luo Y, Zhu W, Wang T, Peng M, Li S, Jie S, Peng A, Wei Y, Chen L.
    J Med Chem; 2011 Oct 13; 54(19):6469-81. PubMed ID: 21853991
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis.
    Chang DJ, An H, Kim KS, Kim HH, Jung J, Lee JM, Kim NJ, Han YT, Yun H, Lee S, Lee G, Lee S, Lee JS, Cha JH, Park JH, Park JW, Lee SC, Kim SG, Kim JH, Lee HY, Kim KW, Suh YG.
    J Med Chem; 2012 Dec 27; 55(24):10863-84. PubMed ID: 23186287
    [Abstract] [Full Text] [Related]

  • 6. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT.
    J Ethnopharmacol; 2012 Jun 01; 141(2):721-7. PubMed ID: 21911050
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
    Kolundžija B, Marković V, Stanojković T, Joksović L, Matić I, Todorović N, Nikolić M, Joksović MD.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):65-71. PubMed ID: 24332490
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and antitumour and anti-angiogenesis evaluation of 22 moscatilin derivatives.
    Guan L, Zhou J, Lin Q, Zhu H, Liu W, Liu B, Zhang Y, Zhang J, Gao J, Feng F, Qu W.
    Bioorg Med Chem; 2019 Jun 15; 27(12):2657-2665. PubMed ID: 31047774
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of nicotinamide derivative as anti-angiogenic agents.
    Choi HE, Choi JH, Lee JY, Kim JH, Kim JH, Lee JK, Kim GI, Park Y, Chi YH, Paik SH, Lee JH, Lee KT.
    Bioorg Med Chem Lett; 2013 Apr 01; 23(7):2083-8. PubMed ID: 23453071
    [Abstract] [Full Text] [Related]

  • 13. Crystal structure of tubulin-barbigerone complex enables rational design of potent anticancer agents with isoflavone skeleton.
    Yan W, Li Y, Liu Y, Wen Y, Pei H, Yang J, Chen L.
    Phytomedicine; 2023 Jan 01; 109():154550. PubMed ID: 36610121
    [Abstract] [Full Text] [Related]

  • 14. Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs.
    Zhang Y, Zhong H, Lv Z, Zhang M, Zhang T, Li Q, Li K.
    Eur J Med Chem; 2013 Apr 01; 62():158-67. PubMed ID: 23353737
    [Abstract] [Full Text] [Related]

  • 15. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
    Zhang S, Cao Z, Tian H, Shen G, Ma Y, Xie H, Liu Y, Zhao C, Deng S, Yang Y, Zheng R, Li W, Zhang N, Liu S, Wang W, Dai L, Shi S, Cheng L, Pan Y, Feng S, Zhao X, Deng H, Yang S, Wei Y.
    Clin Cancer Res; 2011 Jul 01; 17(13):4439-50. PubMed ID: 21622720
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological activity of Schiff base series of valproyl, N-valproyl glycinyl, and N-valproyl-4-aminobenzoyl hydrazide derivatives.
    El-Faham A, Farooq M, Khattab SN, Elkayal AM, Ibrahim MF, Abutaha N, Wadaan MA, Hamed EA.
    Chem Pharm Bull (Tokyo); 2014 Jul 01; 62(6):591-9. PubMed ID: 24881666
    [Abstract] [Full Text] [Related]

  • 17. IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities.
    Li YB, Wang ZQ, Yan X, Chen MW, Bao JL, Wu GS, Ge ZM, Zhou DM, Wang YT, Li RT.
    Cancer Lett; 2013 Oct 28; 340(1):88-96. PubMed ID: 23856030
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.